Feature Story
3.4 million Americans could be diagnosed with skin cancer in 2022
TUESDAY, May 17 (The Washington Post) — Roughly 3.4 million U.S. residents will be diagnosed with skin cancer in 2022, according to estimates compiled by the American Cancer Society and the American Society of Clinical Oncologists.
The vast majority (3.3 million) will have basal cell or squamous cell carcinoma, while the others (99,780 people) will have melanoma — the less common but more dangerous type of skin cancer. Cancer experts predict that 7,650 residents will die of melanoma this year.
In other news. . .
Prostate cancer screening is better than originally thought, especially for Black men, study says
May 17, CNN
Nearly Half of High-Risk Patients Delay Follow-Up After Lung Cancer Screening
May 18, U.S. News & World Report
Sexual minority individuals less likely to undergo cervical cancer screening
May 17, Healio
Obesity Stigma Keeps Many From Life-Saving Cancer Screening: Study
May 19, U.S. News & World Report
Foundation News
Momentum grows for the Medicare Multi-Cancer Early Detection Screening Coverage Act
When it comes to cancer, we need time on our side. Finding cancer early leads to more effective, efficient treatment and a better quality of life for patients and their loved ones.
Today, routine screening is available for only five types of cancer, which leaves the vast majority of cancers without available screening tests. But when cancer is detected early, nine of every 10 cancer patients will live five years or longer.
Over 400 advocacy organizations from all 50 states are joining the Prevent Cancer Foundation in urging Congress to pass the Medicare Multi-Cancer Early Detection Screening Coverage Act, which will create the pathway for seniors to be able to access game-changing cancer technologies when approved by the FDA.
